Imaxio logo — A Lyon and Saint Beauzire-based biopharmaceutical specialist...

Imaxio

A Lyon and Saint Beauzire-based biopharmaceutical specialist in vaccines and genomics.

Founded 2000 Series A Total: $2.90M Biopharma, Biotechnology

General Information

Company Name Imaxio
Founded Year 2000
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Imaxio. To contact Imaxio, visit imaxio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Imaxio compare?

A PDF of Imaxio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Imaxio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Imaxio

Imaxio is a Lyon and Saint Beauzire-based biopharmaceutical specialist that was founded in 2000. The company operates in the biopharma and biotechnology industries, focusing on vaccines and genomics. Imaxio secured a noteworthy €2.90M Series A investment on 17 April 2012. This substantial investment demonstrates confidence in the company's potential and signifies a significant milestone in its growth. The lack of specific information about the investors behind this funding round is notable and may warrant further investigation. Imaxio’s dedication to the critical areas of vaccines and genomics positions it as a compelling player in the biopharmaceutical landscape, making it a company to watch in the coming years.

Business keywords: biopharmaceutical, vaccines, genomics, biotech, pharmaceuticals, Lyon, Saint Beauzire, France, life sciences, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €2.90M -
17 Apr 2012

Imaxio Alternatives & Competitors

View All Alternatives
Imaxio vs
HilleVax
HilleVax United States

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel va...

Post-IPO Equity
76 employees
Biopharma, Biotechnology
Imaxio vs
Athersys
Athersys United States

Committed to developing therapies to extend and enhance the quality of life.

Post-IPO Equity
37 employees
Biopharma, Biotechnology
Imaxio vs
Gordion Bioscience
Gordion Bioscience United States

MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING

7 employees
Biopharma, Biotechnology

FAQ About Imaxio

A Lyon and Saint Beauzire-based biopharmaceutical specialist in vaccines and genomics.
Imaxio was founded in 2000.
Imaxio operates in Biopharma and Biotechnology. Its work centres on biopharmaceutical, vaccines, genomics and biotech.
Imaxio has completed 1 funding round, raising a total of $2.90M. The latest funding stage is Series A.
Top alternatives and competitors to Imaxio include HilleVax, Athersys, Gordion Bioscience, Emmes, Advaccine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imaxio and HilleVax are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Imaxio, https://bouncewatch.com/company/imaxio, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes